SELECTIVE FOLLICULAR REDUCTION FOLLOWING OVULATION INDUCTION BY EXOGENOUS GONADOTROPINS IN POLYCYSTIC OVARIAN DISEASE - A NEW APPROACH TO TREATMENT

被引:13
作者
INGERSLEV, HJ
机构
[1] Department of Obstetrics and Gynaecology, University Hospital
关键词
POLYCYSTIC OVARIAN DISEASE; FOLLICULAR REDUCTION; OVULATION INDUCTION;
D O I
10.1093/oxfordjournals.humrep.a137406
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Seven patients with polycystic ovarian disease (PCO) and having polyfollicular development following ovulation induction by human menopausal gonadotrophin underwent selective follicular reduction by transvaginal ultrasound-guided aspiration of all follicles greater-than-or-equal-to 10 mm in diameter leaving two or three preovulatory mature follicles. Twenty-four and 48 h after injection of human chorionic gonadotrophin, the couples had intercourse. Five patients achieved pregnancy in 15 treatment cycles, four in their first cycle after 14 previous unsuccessful stimulation cycles. Four have delivered healthy children: three singletons and one set of twins. One patient spontaneously aborted twins in week 22 of pregnancy. No major complications were encountered. Selective follicular reduction seems to be a possible approach to the treatment of PCO patients having polyfollicular development following ovulation induction.
引用
收藏
页码:682 / 684
页数:3
相关论文
共 9 条
  • [1] ULTRASONICALLY GUIDED FOLLICULAR ASPIRATION DURING A PREGNANCY WITH MASSIVE OVARIAN CYSTS FOLLOWING OVULATION INDUCTION BY GONADOTROPINS
    MURASE, T
    IMAI, A
    ITOH, N
    TAMAYA, T
    FERTILITY AND STERILITY, 1993, 59 (05) : 1132 - 1134
  • [2] THE DURATION OF LEUPROLIDE ACETATE ADMINISTRATION PRIOR TO OVULATION INDUCTION DOES NOT IMPACT OVARIAN RESPONSIVENESS TO EXOGENOUS GONADOTROPINS
    SCOTT, RT
    NEAL, GS
    ILLIONS, EH
    HAYSLIP, CA
    HOFMANN, GE
    FERTILITY AND STERILITY, 1993, 60 (02) : 247 - 253
  • [3] Successful ovulation induction by sandostatin-therapy of polycystic ovarian disease
    Wenzl, R
    Lehner, R
    Schurz, B
    Karas, H
    Huber, JC
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1996, 75 (03) : 298 - 299
  • [4] LUTEAL FUNCTION FOLLOWING OVULATION INDUCTION IN POLYCYSTIC-OVARY-SYNDROME PATIENTS USING EXOGENOUS GONADOTROPINS IN COMBINATION WITH A GONADOTROPIN-RELEASING-HORMONE AGONIST
    DONDERWINKEL, PFJ
    SCHOOT, DC
    PACHE, TD
    DEJONG, FH
    HOP, WCJ
    FAUSER, BCJM
    HUMAN REPRODUCTION, 1993, 8 (12) : 2027 - 2032
  • [5] A COMPARATIVE-STUDY OF 3 OVULATION INDUCTION PROTOCOLS IN POLYCYSTIC OVARIAN DISEASE PATIENTS IN AN INVITRO FERTILIZATION EMBRYO TRANSFER PROGRAM
    TURHAN, NO
    ARTINI, PG
    DAMBROGIO, G
    DROGHINI, F
    BATTAGLIA, C
    GENAZZANI, AD
    VOLPE, A
    GENAZZANI, AR
    JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 1993, 10 (01) : 15 - 20
  • [6] OVULATION INDUCTION IN POLYCYSTIC-OVARY-SYNDROME - A REVIEW OF CONSERVATIVE AND NEW TREATMENT MODALITIES
    MEIROW, D
    LAUFER, N
    SCHENKER, JG
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 1993, 50 (02) : 123 - 131
  • [7] OVULATION INDUCTION WITH LOW-DOSES OF PURE FOLLICLE-STIMULATING-HORMONE USING A FIXED PROTOCOL IN PATIENTS WITH POLYCYSTIC OVARIAN DISEASE
    BREGIEIRO, LOR
    DEMOURA, MD
    FERRIANI, RA
    BAILAO, LA
    DESA, MFS
    INTERNATIONAL JOURNAL OF FERTILITY, 1993, 38 (03) : 152 - 159
  • [8] GROWTH-PATTERNS OF OVARIAN FOLLICLES DURING INDUCTION OF OVULATION WITH DECREASING DOSES OF HUMAN MENOPAUSAL GONADOTROPIN FOLLOWING PRESUMED SELECTION IN POLYCYSTIC-OVARY-SYNDROME
    SCHOOT, DC
    PACHE, TD
    HOP, WC
    DEJONG, FH
    FAUSER, BCJM
    FERTILITY AND STERILITY, 1992, 57 (05) : 1117 - 1120
  • [9] Serum anti-Mullerian hormone and inhibin B concentrations are not useful predictors of ovarian response during ovulation induction treatment with recombinant follicle-stimulating hormone in women with polycystic ovary syndrome
    Fong, Sharon Lie
    Schipper, Izaak
    de Jong, Frank H.
    Themmen, Axel P. N.
    Visser, Jenny A.
    Laven, Joop S. E.
    FERTILITY AND STERILITY, 2011, 96 (02) : 459 - 463